Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$72,206
+$3,236 QoQ
Shares Held
776
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#206
of 282 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAMCO INC /NY/ holds $406,272,438 across 24 Biotechnology names. BNTX ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
1,989,386 | $139,316,701 | |
| 2 | ARGX |
Argenx SE
|
136,654 | $126,783,481 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,253,120 | $32,856,806 | |
| 4 | ZLAB |
Zai Lab Ltd
|
1,623,694 | $30,850,186 | |
| 5 | MANE |
Veradermics, Inc
|
229,581 | $28,224,688 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
520,108 | $24,465,880 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
125,000 | $4,423,750 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,000 | $2,980,380 |
All Filings in BNTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,206 | 776 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $68,970 | 776 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $73,875 | 776 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $520,319 | 5,276 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $561,735 | 5,276 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $698,885 | 7,675 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,385,657 | 20,936 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,206,033 | 18,574 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $791,546 | 9,850 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,175,321 | 251,223 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,577,407 | 242,348 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,264,091 | 158,911 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,687,314 | 71,225 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,905,384 | 71,489 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,739,077 | 71,489 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,421,773 | 92,095 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,200,093 | 75,118 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,533,608 | 67,622 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,145,007 | 78,142 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $54,271,503 | 198,804 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $72,487,194 | 323,777 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $27,622,558 | 252,977 | Shares | Defined | 2021-05-19 | |
| 2020-12-31 | $11,898,903 | 145,963 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||